Omega Therapeutics, Inc. Common Stock
OMGA
OMGA was delisted on the 24th of February, 2025.
52 hedge funds and large institutions have $272M invested in Omega Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 5 closing their positions.
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
122% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 9
16% more funds holding
Funds holding: 45 → 52 (+7)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
43% less capital invested
Capital invested by funds: $480M → $272M (-$208M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$8.92M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.34M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.49M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4M |
| 2 |
SOMRS
State of Michigan Retirement System
Lansing,
Michigan
|
-$3.33M |
| 3 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$3.24M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.07M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$768K |
OMGA Hedge Fund Activity: Q1 2022 in Review
52 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Omega Therapeutics, Inc. Common Stock (OMGA) for Q1 2022, worth a combined $272M — down 43% from $480M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new OMGA positions and 5 closed out — a net gain of 7 holders — while 20 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock, adding an estimated $8.92M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $4M sold.
- 52 institutional investors held Omega Therapeutics, Inc. Common Stock (OMGA) as of Q1 2022, up from 45 in Q4 2021.
- Funds reported $272M of Omega Therapeutics, Inc. Common Stock stock for Q1 2022, down 43% quarter-over-quarter.
- 12 funds opened new Omega Therapeutics, Inc. Common Stock positions in Q1 2022 and 5 closed out, a net change of +7 holders.
- The largest Omega Therapeutics, Inc. Common Stock buyer in Q1 2022 was BlackRock, an estimated $8.92M added.
- The largest Omega Therapeutics, Inc. Common Stock seller in Q1 2022 was Sphera Funds Management, an estimated $4M sold.
Based on aggregated 13F filings for Q1 2022.